Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Management of Elevated Liver Enzymes

Diagnostic Approach

  • The American Gastroenterological Association recommends a comprehensive liver etiology workup including viral hepatitis panel, autoimmune markers, iron studies, and abdominal ultrasound to determine the underlying cause of elevated liver enzymes in patients with elevated alkaline phosphatase, total protein, and globulin 1
  • The European Association for the Study of the Liver suggests that an elevated globulin with normal albumin suggests possible inflammatory or autoimmune process, with a strength of evidence level of II-2 2
  • The presence of a hepatocellular pattern with elevated alkaline phosphatase, total protein, and globulin, with normal transaminases and bilirubin, warrants further investigation, according to the American Association for the Study of Liver Diseases 1

Core Diagnostic Workup

  • The standard liver etiology screen (core panel) should include viral hepatitis markers, autoimmune markers, iron studies, and abdominal ultrasound, as recommended by the American College of Gastroenterology 1, 2
  • Additional autoimmune markers, such as ANA and anti-mitochondrial antibody, should be tested since only smooth muscle antibody has been tested, with a strength of evidence level of II-2 2, 4
  • Iron studies, including serum ferritin and transferrin saturation, should be assessed to evaluate for hemochromatosis, according to the European Association for the Study of the Liver 2

Further Evaluation Based on Initial Results

  • If cholestatic pattern is confirmed, consider MRCP to evaluate for primary sclerosing cholangitis or other biliary disorders, as recommended by the American Gastroenterological Association 1, 4
  • If autoimmune markers are positive, consider liver biopsy to confirm autoimmune hepatitis or overlap syndrome, with a strength of evidence level of II-2 1, 3

Important Considerations

  • The American Association for the Study of Liver Diseases recommends that repeating the same panel of liver tests without investigating the cause is not sufficient, as 84% of abnormal tests remain abnormal on retesting after 1 month 1, 2
  • Even at 2 years, 75% of abnormal liver tests remain abnormal without intervention, highlighting the need for a comprehensive diagnostic approach 1

Referral Criteria

  • Consider referral to a gastroenterologist/hepatologist if the etiology remains unclear after initial workup, or if there is evidence of advanced liver disease or fibrosis, as recommended by the American College of Gastroenterology 1, 5

Monitoring Recommendations

  • If a specific diagnosis is made, follow appropriate disease-specific monitoring, according to the European Association for the Study of the Liver 1
  • For patients with NAFLD, monitor liver enzymes every 3-6 months initially, as recommended by the American Association for the Study of Liver Diseases 5
  • Annual monitoring for development of complications in patients with chronic liver disease is recommended by the American Gastroenterological Association 6